FDA.reportPublic FDA data

Fluticasone Propionate and Salmeterol

Product NDC
50090-4213
11-digit product format
500904213
Labeler code
50090
Product ID
50090-4213_0bd79006-13e5-4b32-b23e-e787bc8e0b0d
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
fluticasone propionate and salmeterol
Dosage form
POWDER
Route
RESPIRATORY (INHALATION)
Labeler
A-S Medication Solutions
Application
NDA021077
Marketing category
NDA AUTHORIZED GENERIC
Marketing start
2019-02-08
Substance
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
Active strength
250; 50 ug/1; ug/1
Pharmacologic classes
Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Fluticasone Propionate and Salmeterol
Brand name suffix
DISKUS
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
FLUTICASONE PROPIONATE250 ug/1
SALMETEROL XINAFOATE50 ug/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiO2GMZ0LF5W, 6EW8Q962A5
Rxcui896209

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
f4fb2f5a-dadb-40e3-a4b1-a2a58f5d9a33Product name320260126
343e8617-eb68-1e10-cfa9-8c30af285764Product name320240513
a31ad3df-8021-2ea1-94eb-0fe2f49b7729Product name420220719
813fe018-3e3c-40e4-8f71-7ab50f3dfe81Product name220180723
3bcd721e-0555-4bc3-96c6-690471ff9d94Product name120171113
9f9452df-fa34-43d4-97fe-c6605344c5a8Product name120171113
0e5a25a6-9f05-44b5-8449-aa63e59f7202Product name120170426
f3c5232f-03de-44f5-996a-90cd9c08bc60Product name120170426
1cb17fbb-0da4-2841-37bc-e7079783e1a2Product name120140508
667f427a-8698-a508-767a-53ed61b4c2e9Product name120140508
6a97ffc8-1d4d-a971-4978-85ba3a22eac9Product name120140508
6df84e13-2223-fa46-1e26-17e2f58a1e1cProduct name120140508
811691fa-281f-6d95-fb49-e2337fb2e146Product name120140508
90fec588-984c-4375-cfd4-7e40114bdf80Product name120140508
9c1d3c48-b162-204b-f55b-e0f25c31c52eProduct name120140508
9fdb6139-394b-1510-4baf-bde68c419789Product name120140508
aef26912-037b-9a4e-db49-225ef6dfd8f1Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
50090-4213-02023-02-07C16284748780-1f386c649-c326-0266-e053-dadaa90a7c1aThese highlights do not include all the information needed to use Fluticasone Propionate/Salmeterol DISKUS safely and effectively. See full prescribing information for Fluticasone Propionate/Salmeterol DISKUS. Fluticasone Propionate/Salmeterol DISKUS inhalation powder, for oral inhalation use Initial U.S. Approval: 2000
50090-4213-02023-01-30C16284748780-1f386c649-c326-0266-e053-dadaa90a7c1aThese highlights do not include all the information needed to use Fluticasone Propionate/Salmeterol DISKUS safely and effectively. See full prescribing information for Fluticasone Propionate/Salmeterol DISKUS. Fluticasone Propionate/Salmeterol DISKUS inhalation powder, for oral inhalation use Initial U.S. Approval: 2000

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50090-4213-0Fluticasone Propionate and SalmeterolDISKUS60 in 1 INHALERPOWDER6012
50090-4213-0Fluticasone Propionate and SalmeterolDISKUS1 in 1 CARTONPOWDER112

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50090-4213-0EA - Each50090-421338111aa9-c5d8-499a-bf5a-8275abd4913e12022-01-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50090-4213FLUTICASONE PROPIONATE AND SALMETEROL DISKUS (FLUTICASONE PROPIONATE AND SALMETEROL) POWDER [A-S MEDICATION SOLUTIONS]12Current NDC, Legacy NDC, 2 package rows20240123_9e237635-6975-4930-9ce1-051d9e3bf615.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
896209fluticasone propionate/salmeterol 250/50 MCG/INHAL Dry Powder Inhaler, 60 BlistersPSN9e237635-6975-4930-9ce1-051d9e3bf61512
89620960 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder InhalerSCD9e237635-6975-4930-9ce1-051d9e3bf61512
896209fluticasone propionate 0.25 MG / salmeterol 0.05 MG per ACTUAT Dry Powder Inhaler, 60 ACTUATSY9e237635-6975-4930-9ce1-051d9e3bf61512
896209fluticasone propionate 250 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler, 60 ACTUATSY9e237635-6975-4930-9ce1-051d9e3bf61512

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
50090-4213-0500904213001 INHALER in 1 CARTON (50090-4213-0) / 60 POWDER in 1 INHALER1 inhaler2019-03-250000-00-00NoNoCurrent